XOM Research Update — August 28, 2026
Updated Thesis
Exxon Mobil is a globally integrated oil and gas company spanning upstream production, refining and marketing, chemicals, specialty products, LNG and selected lower-carbon businesses. Business quality is high because its scale, integrated asset base, low-cost positions in Guyana and the Permian, proprietary operating capabilities and disciplined capital returns support resilient competitive positioning across commodity cycles; management reported $16.3 billion of structural cost savings versus 2019 and net debt-to-capital of 10.7% at June 30, 2026. Growth is currently strong, with revenue up 44.1% and earnings up 105.1% year over year in the most recent quarter, although those results benefited from higher crude prices and refining margins.
The investment grade as of this refresh is C — average business quality. High-tier business, expensive-tier valuation, with 1.6% downside to $153.96 fair value.
Key Metrics at a Glance
- Revenue growth: +44.1% year over year
- Net margin: 9.1%
- Fair value upside: -1.6% to our estimate of $154
Current price: $156.45
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Exxon Mobil Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full XOM research →](/stocks/XOM)